Need access to approved concise, visual, clinical decision making resources? Download our Infographic booklet featuring key decision making graphics from an ADA/EASD Consensus Guidelines article published in Diabetologia journal.

Clinical inertia (failure to intensify treatment when treatment targets are not met) contributes to diabetes progression and complications. One reason for clinical inertia is physicians not knowing how to intensify treatment given the complexity of available treatment options today. Physicians need practical, evidence-based guidance on giving the right treatment at the right time to the right patient.

The recent ADA/EASD consensus report provides this guidance and recommends earlier use of specific GLP-1RAs and SGLT2 inhibitors, particularly in patients with established cardiovascular or renal disease. There is a need to reinforce the importance and implications of this consensus for physicians worldwide with respect to their local healthcare systems.

A lack of time and unfamiliarity with the efficacy and safety of these medications may mean that conventional regimens (e.g. metformin and sulfonylureas) are more commonly prescribed, while these new options with potentially greater efficacy and cardiovascular benefits are overlooked.

This downloadable booklet features key infographics, reproduced with permission from Diabetologia, offering diabetes physicians direct access to these valuable, visual and easy-to-use clinical decision-making resources.

Scroll to Top